Marijuana Business Startups Pay State $1.8 Million In 1st Day of Licensing

0
854

The Oklahoma Medical Marijuana Authority(OMMA) reports brisk online application traffic to their website in the first 23 hours of operations. 729 total business groups or proprietors presented their business plans and requested operational licenses. Growers were the biggest classification of  Medical Marijuana Businesses(MMB) that were processed in to the OMMA’s database for review and granting of 1 year licenses. Each MMB application costs $2500.

The growing of cannabis(botanical name of the marijuana plant)  is the integral 1st step in eventually providing marijuana medicines to the patients whose physicians recommend this course of treatment.

Interim Health Dept Director, Tom Bates, foresees nearly 80,000 licensed patients in the first year of the OMMA.   About 2000 MMB licenses are expected to be submitted.

The biggest obstacle patients currently face is a severe lack of physician training in the endocannabinoid system of the human body and how to utilize the herbal medicines in a therapeutic treatment for conditions.

Oklahoma’s new MMBs will do well to provide clinicians with informative training on how to best use the medicines they produce, in the care for the suffering patients.  Big pharma has long been the first line trainers whom physicians rely on for training on new drugs. the patent-holding pharmaceuticals have a huge financial stake in this key training initiative.

The Cannabinoids affect the nervous system in a myriad of ways to treat brain disorders. Patients with PTSD, clinical Anxiety disorder, panic attacks, and other mental health challenges

  The biggest obstacle patients currently face is a severe lack of physician training in the endocannabinoid system of the human body and how to utilize the herbal medicines in a therapeutic treatment for conditions.

Oklahoma’s new MMBs will do well to provide clinicians with informative training on how to best use the medicines they produce, in the care for the suffering patients.  Big pharma has long been the first line trainers whom physicians rely on for training on new drugs. the patent-holding pharmaceuticals have a huge financial stake in this key training initiative.


The Cannabinoids affect the nervous system in a myriad of ways to treat brain disorders. Patients with PTSD, clinical Anxiety disorder, panic attacks, and other mental health challenges
  Chronic pain sufferers are some of the most desperate patients seeking the more effective medicines where THC works in a synergistic interaction with the CBD oils that were made legal just 4 years ago.  Elderly with severe arthritis and other maladies now have this safer course of treatment when their opioid medicines quit being effective.

Cancer patients rely on cannabis medicines to get relief from the severe and debilitating nausea that chemotherapy creates. It allows them to keep food and liquids down and thus maintain their strength to fight the cancer in the most aggressive ways.

Optometrists are arbitrarily banned by the state health dept., from authorizing or recommending cannabis medicines, even though the language of SQ788 provided for them to.  In remote areas of Oklahoma, these physicians have no MD eye specialists to work with when a glaucoma (ocular hypertension) presents itself.Image result for Marijuana Business Startups Pay State $1.8 Million In 1st Day of Licensing

LEAVE A REPLY

Please enter your comment!
Please enter your name here